Clinical Trial Update: Beta-hCG + Erythropoietin in Acute Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of beta-hCG and erythropoietin for acute ischemic stroke; the study has completed and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Erythropoietin (erythropoietin)
• beta-hCG (human chorionic gonadotropin (beta subunit))

Snippet

Sponsor: University of California, Irvine | Conditions: Acute Stroke | Phase 2 | Status: COMPLETED | Results posted: 2016-08-29